These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17565631)

  • 1. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
    Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC; Chitturi S; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract]   [Full Text] [Related]  

  • 5. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
    Chitturi S; Farrell GC; George J
    J Gastroenterol Hepatol; 2004 Apr; 19(4):368-74. PubMed ID: 15012772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current trends of NASH/NAFLD in Asia-Pacific region].
    Ishii H
    Nihon Rinsho; 2006 Jun; 64(6):1017-9. PubMed ID: 16768103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
    Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.
    Leoni S; Tovoli F; Napoli L; Serio I; Ferri S; Bolondi L
    World J Gastroenterol; 2018 Aug; 24(30):3361-3373. PubMed ID: 30122876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease guidelines: an Asian perspective.
    Ishii H; Kajihara M
    J Gastroenterol Hepatol; 2007 Jun; 22(6):769-70. PubMed ID: 17565626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
    Kieć-Wilk B; Klupa T; Dembińska-Kieć A
    Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease.
    Parkash O; Hamid S
    J Pak Med Assoc; 2013 Jan; 63(1):95-9. PubMed ID: 23865141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of non-alcoholic fatty liver disease in China.
    Fan JG; Farrell GC
    J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.
    Karlas T; Wiegand J; Berg T
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):195-208. PubMed ID: 23731881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico].
    Roesch-Dietlen F; Dorantes-Cuéllar A; Carrillo-Toledo MG; Martínez-Sibaja C; Rojas-Carrera S; Bonilla-Rojas QC; Uchino-Higueras V; Lagunas T; Carrasco-Arróniz MA; Soler-Leal B; León-Valdivieso J; Cid-Juárez S; Martínez JA
    Rev Gastroenterol Mex; 2006; 71(4):446-52. PubMed ID: 17542277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.